相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Link between Gut Dysbiosis and Neuroinflammation in Parkinson's Disease
Jose Fidel Baizabal-Carvallo et al.
NEUROSCIENCE (2020)
Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson's Disease
Tobias Hegelmaier et al.
CELLS (2020)
Clinical and metabolic response to probiotic administration in people with Parkinson's disease: A randomized, double-blind, placebo-controlled trial
Omid Reza Tamtaji et al.
CLINICAL NUTRITION (2019)
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
Vayu Maini Rekdal et al.
SCIENCE (2019)
Severe Constipation in Parkinson's Disease and in Parkinsonisms: Prevalence and Affecting Factors
Giuseppe Frazzitta et al.
FRONTIERS IN NEUROLOGY (2019)
Small Intestinal Bacterial Overgrowth: Clinical Features and Therapeutic Management
Satish S. C. Rao et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2019)
Effects of bowel preparation on the human gut microbiome and metabolome
Naoyoshi Negata et al.
SCIENTIFIC REPORTS (2019)
l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?
Anna R. Carta et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2017)
Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth
L. Gatta et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Persisting changes of intestinal microbiota after bowel lavage and colonoscopy
Lorenzo Drago et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2016)
Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous L-DOPA delivery in the 6-OHDA model of Parkinson's disease
Giovanna Mulas et al.
EXPERIMENTAL NEUROLOGY (2016)
Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson's disease
Xiao-Lu Niu et al.
JOURNAL OF NEURAL TRANSMISSION (2016)
Colonic Bacterial Composition in Parkinson's Disease
Ali Keshavarzian et al.
MOVEMENT DISORDERS (2015)
Effects of bowel cleansing on the intestinal microbiota
Jonna Jalanka et al.
GUT (2015)
Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome
Doron Boltin et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2014)
The role of small intestinal bacterial overgrowth in Parkinson's disease
Alfonso Fasano et al.
MOVEMENT DISORDERS (2013)
Impact of Colonoscopy Bowel Preparation on Intestinal Microbiota
Claire L. O'Brien et al.
PLOS ONE (2013)
Standard Colonic Lavage Alters the Natural State of Mucosal-Associated Microbiota in the Human Colon
Laura Harrell et al.
PLOS ONE (2012)
Fecal Impaction: A Cause for Concern?
Izi Obokhare
Clinics in Colon and Rectal Surgery (2012)
Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease
Christopher B. Forsyth et al.
PLOS ONE (2011)
Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat:: Role for interleukin-1β
C. J. Barnum et al.
NEUROSCIENCE (2008)
Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations
J Jankovic
MOVEMENT DISORDERS (2005)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
分享论文
